4
Changes in Ownership
MANNKIND CORP Filed Acc 0001209191-22-028679
EVP Endocrine Business Unit acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Galindo Alejandro · EVP Endocrine Business Unit
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-05-10 | Grant or award : show line 1 in the form | +90,000 | 666,690 | D |
| 2022-05-10 | Grant or award : show line 2 in the form | +110,000 | 776,690 | D |
Loading xslF345X03/doc4.xml…